Tobacco Use and Cessation Strategies Among Individuals Recently Diagnosed with Cancer

Clicks: 1
ID: 319068
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #115 of 122 articles by views in nicotine & tobacco research : official journal of the society for research on nicotine and tobacco

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 122 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract INTRODUCTION Smoking cessation following a cancer diagnosis is critical for improving prognosis. For this reason, substantial efforts have been made to increase tobacco treatment in cancer care settings. The purpose of the present study is to provide an up-to-date estimate of tobacco/nicotine product use (inclusive of non-combustible products such as e-cigarettes and oral nicotine pouches) and cessation strategy uptake among individuals recently diagnosed with cancer. METHODS Data were derived from the Population Assessment of Tobacco and Health study, a large, nationally representative survey. Weighted frequencies estimated tobacco/nicotine product use (e.g., cigarettes, cigars, e-cigarettes, oral pouches) and cessation strategy prevalence (e.g., nicotine replacement therapies, prescription medications, e-cigarettes, oral pouches). Logistic regressions evaluated associations between cancer diagnosis and cancer type (e.g., tobacco related vs. non-tobacco related cancers) on tobacco use and cessation strategy outcomes. RESULTS Individuals with cancer used tobacco/nicotine products at similar rates as those without cancer. Individuals with cancer were more likely to use evidence-based cessation strategies (e.g., pharmacotherapy and counseling; AOR=2.36 [95% CI 1.30-4.27], p<.01), but appeared less likely to successfully quit (17.27% [5.42-29.13]) with cancer quit vs 31.16% [28.39-33.93] without cancer). Similarly, those with tobacco-related cancers appeared to have higher engagement with cessation strategies (11.90% [5.95 - 17.84]) than those with non-tobacco-related cancers (2.35% [0.74 - 3.95]). CONCLUSIONS Efforts to increase reach and access to evidence-based cessation support in cancer settings have been fruitful; however, more work is needed to improve treatment effectiveness. Continued monitoring of the use of non-combustible products is warranted.
Reference Key
openalex_W7166542791 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Amanda Palmer, Kinsey Pebley, Andrew A. Chen, Tracy Smith, Alana M. Rojewski
Journal nicotine & tobacco research : official journal of the society for research on nicotine and tobacco
Year 2026
DOI
10.1093/ntr/ntag145
URL
https://doi.org/10.1093/ntr/ntag145
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.